Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration.

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration.
复制标题

DOI:
10.1093/jnci/djy088
复制
发表时间:
2018-08-01
期刊:
Journal of the National Cancer Institute
影响因子:
--
通讯作者:
Altman DG
Altman DG
中科院分区:
其他
文献类型:
--
作者:
Sauerbrei W;Taube SE;McShane LM;Cavenagh MM;Altman DG

文献摘要

参考文献

被引文献

相似文献

肿瘤标志物预后研究的报告建议(REMARK)旨在解决此类研究报告中的普遍缺陷。REMARK检查表包括20个项目,用于报告已发表的肿瘤标志物预后研究。发表了一份详细的文件,解释了清单项目的理由,提供了积极的例子,并提供了报告质量的经验证据。REMARK提供了一个全面的概述,以教育良好的报告,并提供了一个有价值的参考,为许多问题时,考虑设计,进行和分析肿瘤标志物研究和预后研究的医学一般。尽管主要癌症期刊支持REMARK,但预后因素研究报告仍然很少。为了鼓励REMARK的传播和吸收,我们制作了这份详细解释性手稿的相当精简的版本,这也可以作为计划肿瘤标志物预后研究的研究人员关键问题的简要指南。为了总结目前的情况,引用了最近调查报告质量和相关报告指南的论文,但其他文献没有更新。这篇论文的另一个重要推动力是,它可以作为直译成其他语言的基础。翻译将有助于将关键信息带给世界各地的更多受众。更多的细节可以在原始文件中找到。
The Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK) were developed to address widespread deficiencies in the reporting of such studies. The REMARK checklist consists of 20 items to report for published tumor marker prognostic studies. A detailed paper was published explaining the rationale behind checklist items, providing positive examples and giving empirical evidence of the quality of reporting. REMARK provides a comprehensive overview to educate on good reporting and provide a valuable reference for the many issues to consider when designing, conducting, and analyzing tumor marker studies and prognostic studies in medicine in general. Despite support for REMARK from major cancer journals, prognostic factor research studies remain poorly reported. To encourage dissemination and uptake of REMARK, we have produced this considerably abridged version of the detailed explanatory manuscript, which may also serve as a brief guide to key issues for investigators planning tumor marker prognostic studies. To summarize the current situation, more recent papers investigating the quality of reporting and related reporting guidelines are cited, but otherwise the literature is not updated. Another important impetus for this paper is that it serves as a basis for literal translations into other languages. Translations will help to bring key information to a larger audience world-wide. Many more details can be found in the original paper.
DOI: 10.1002/sim.3437
发表时间: 2008-12-30
影响因子: 2
作者:
Beyersmann, Jan;Wolkewitz, Martin;Schumacher, Martin
通讯作者: Schumacher, Martin
DOI: 10.1038/sj.bjc.6604999
发表时间: 2009-04-21
影响因子: 8.8
作者:
Riley RD;Sauerbrei W;Altman DG
通讯作者: Altman DG
DOI: 10.1016/j.jclinepi.2014.11.010
发表时间: 2015-01-06
影响因子: 39.2
作者:
Collins, Gary S.;Reitsma, Johannes B.;Moons, Karel G. M.
通讯作者: Moons, Karel G. M.
下调E-钙粘蛋白(ECAD) - 在口腔和口咽早期鳞状细胞癌的前哨淋巴结活检中,神秘转移性疾病的预测因子。
DOI: 10.1186/1471-2407-11-217
发表时间: 2011-06-03
期刊: BMC cancer
影响因子: 3.8
作者:
Huber GF;Züllig L;Soltermann A;Roessle M;Graf N;Haerle SK;Studer G;Jochum W;Moch H;Stoeckli SJ
通讯作者: Stoeckli SJ
DOI: 10.1093/ajcp/aqx080
发表时间: 2017-10-01
影响因子: 3.5
作者:
Caron, Justin E.;March, Jordon K.;Schmidt, Robert L.
通讯作者: Schmidt, Robert L.